In vivo and in vitro characterization of <scp>GL0034</scp> , a novel long‐acting <scp>glucagon‐like peptide</scp> ‐1 receptor agonist-Reference-Cited by-同舟云学术

In vivo and in vitro characterization of GL0034 , a novel long‐acting glucagon‐like peptide ‐1 receptor agonist

Published:2022-07-18 Issue:11 Volume:24 Page:2090-2101
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Jones Ben¹,Burade Vinod²,Akalestou Elina³,Manchanda Yusman³,Ramchunder Zenouska³,Carrat Gaëlle³,Nguyen‐Tu Marie‐Sophie³,Marchetti Piero⁴,Piemonti Lorenzo⁵^ORCID,Leclerc Isabelle³⁶,Thennati Rajamannar²,Vilsboll Tina⁷,Thorens Bernard⁸,Tomas Alejandra³,Rutter Guy A.³⁶⁹^ORCID

Affiliation:

1. Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine Imperial College London London UK

2. High Impact Innovations—Sustainable Health Solutions Sun Pharmaceutical Industries Limited Vadodara India

3. Section of Cell Biology and Functional Genomics, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine Imperial College London London UK

4. Department of Clinical and Experimental Medicine, Islet Cell Laboratory University of Pisa Pisa Italy

5. Diabetes Research Institute IRCCS Ospedale San Raffaele Milan Italy

6. CRCHUM University of Montréal Montréal Canada

7. Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Gentofte Hospital University of Copenhagen Copenhagen Denmark

8. Center for Integrative Genomics University of Lausanne Lausanne Switzerland

9. Lee Kong Chian School of Medicine Nanyang Technological University Singapore Singapore

Funder

European Commission

European Foundation for the Study of Diabetes

Medical Research Council Canada

Wellcome Trust

Juvenile Diabetes Research Foundation International